41012526 Nonacog beta pegol 1000UI pó sol inj fr IV e Nonacog Beta Pegol 2000 U.I. pó sol inj fr IV
TED · 546733-2026Award notice · social & specific servicesawardedNo deadline given
Value
Estimated€796,019 · 796,018.8 EUR
Awarded€770,296 · 770,295.8 EUR
WinnerNovo Nordisk, Lda
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de São José, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Vertex Pharmaceuticals (Portugal), Unipessoal Lda | 2 | €5,562,837 | 2026-08-07 |
| Roche Sistemas de Diagnósticos, Lda | 2 | €4,637,771 | 2026-08-04 |
| Johnson & Johnson, Lda. | 2 | €1,265,691 | 2026-07-06 |
| Stryker Portugal Produtos Médicos, Lda. | 2 | €869,259 | 2026-08-03 |
| MEDTRONIC PORTUGAL, UNIPESSOAL, LDA. | 2 | €713,450 | 2026-08-03 |
Full buyer profile: what Unidade Local de Saúde de São José, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
41012526 Nonacog beta pegol 1000UI pó sol inj fr IV e Nonacog Beta Pegol 2000 U.I. pó sol inj fr IV
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-17 | 41016726-EPTACOG ALFA (ACTIVADO) 100 K.U.I. (2MG) E 250 K.U.I. (5MG) PÓ SOL INJ FR IV | Unidade Local de Saúde de São José, EPE PT | 92% |
| 2026-07-17 | Ustecinumab 130 mg/26 ml sol inj fr 26 ml IV e Ustecinumab 90 mg/1 ml sol inj caneta 1 ml SC | Unidade Local de Saúde de São José, EPE PT | 92% |
| 2026-07-17 | Rurioctocog Alfa Pegol Pó Sol Inj Fr Iv | Unidade Local de Saúde de Coimbra, EPE PT | 91% |
| 2026-07-17 | Tacrolimus diversas dosagens | Unidade Local de Saúde de São José, EPE PT | 91% |
| 2026-08-03 | 12005526 - Material para Deformidades de Adulto | Unidade Local de Saúde de São José, EPE PT | 91% |
| 2026-06-17 | 12015826 - Material de Osteossíntese Pediátrica | Unidade Local de Saúde de São José, EPE PT | 91% |